BioHarvest Sciences Inc. (CNVCF)
- Previous Close
0.1850 - Open
0.1898 - Bid --
- Ask --
- Day's Range
0.1850 - 0.1900 - 52 Week Range
0.1150 - 0.2200 - Volume
38,659 - Avg. Volume
71,387 - Market Cap (intraday)
95.463M - Beta (5Y Monthly) 1.46
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Apr 29, 2024 - May 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BioHarvest Sciences Inc. operates as a biotechnology company. The company develops botanical synthesis platform technology to grow the ingredients inherent in various fruits and plants without the need to grow the plant itself. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and production organization (CDMO) on behalf of customers seeking various molecules; and as a creator of nutraceutical health and wellness products, which includes dietary supplements. The company's products include VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
www.bioharvest.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CNVCF
Performance Overview: CNVCF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNVCF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNVCF
Valuation Measures
Market Cap
95.46M
Enterprise Value
105.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.07
Price/Book (mrq)
--
Enterprise Value/Revenue
9.94
Enterprise Value/EBITDA
-15.69
Financial Highlights
Profitability and Income Statement
Profit Margin
-76.77%
Return on Assets (ttm)
-61.64%
Return on Equity (ttm)
--
Revenue (ttm)
10.6M
Net Income Avi to Common (ttm)
-8.13M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.56M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-5.84M
Company Insights: CNVCF
CNVCF does not have Company Insights